A randomized trial of pamrevlumab in patients with COVID-19 pneumonia

被引：2
|
作者：
Sgalla, Giacomo [1 ]
Leone, Paolo Maria [1 ]
Gualano, Gina [2 ]
Simonetti, Jacopo [1 ]
Comes, Alessia [1 ]
Verdirosi, Diana [1 ]
Di Gennaro, Francesco [2 ]
Larici, Anna Rita [3 ]
Ianniello, Stefania [4 ]
Cicchetti, Giuseppe [3 ]
Fusco, Nicoletta [4 ]
Pani, Marcello [5 ]
Palmieri, Fabrizio [2 ]
Richeldi, Luca [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, UOC Pneumol, Rome, Italy
[2] Ist Nazl Malattie Infett Lazzaro Spallanzani IRCCS, UOC Malattie Infett Apparat Resp, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia Oncolo, Rome, Italy
[4] Ist Nazl Malattie Infett Lazzaro Spallanzani IRCCS, UOSD Diagnost Immagini nelle Malattie Infett, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, UOC Farm, Rome, Italy
来源：
RESPIROLOGY | 2023年 / 28卷 / 10期
关键词：
COVID-19; interstitial lung disease; lung fibrosis; pulmonary fibrosis;
D O I：
10.1111/resp.14575
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：954 / 957
页数：4
相关论文
共 50 条
  • [1] A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
    Simonovich, V. A.
    Pratx, L. D. Burgos
    Sabana, P.
    Beruto, M., V
    Vallone, M. G.
    Vazquez, C.
    Savoy, N.
    Giunta, D. H.
    Perez, L. G.
    Sanchez, M. L.
    Gamarnik, A., V
    Ojeda, D. S.
    Santoro, D. M.
    Camino, P. J.
    Antelo, S.
    Rainero, K.
    Vidiella, G. P.
    Miyazaki, E. A.
    Cornistein, W.
    Trabadelo, O. A.
    Ross, F. M.
    Spotti, M.
    Funtowicz, G.
    Scordo, W. E.
    Losso, M. H.
    Ferniot, I
    Pardo, P. E.
    Rodriguez, E.
    Rucci, P.
    Pasquali, J.
    Fuentes, N. A.
    Esperatti, M.
    Speroni, G. A.
    Nannini, E. C.
    Matteaccio, A.
    Michelangelo, H. G.
    Follmann, D.
    Lane, H. C.
    Belloso, W. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 619 - 629
  • [2] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Ivan O. Rosas
    George Diaz
    Robert L. Gottlieb
    Suzana M. Lobo
    Philip Robinson
    Bradley D. Hunter
    Adilson W. Cavalcante
    J. Scott Overcash
    Nicola A. Hanania
    Alan Skarbnik
    Julia Garcia-Diaz
    Ivan Gordeev
    Jordi Carratalà
    Oliver Gordon
    Emily Graham
    Nicholas Lewin-Koh
    Larry Tsai
    Katie Tuckwell
    Huyen Cao
    Diana Brainard
    Julie K. Olsson
    Intensive Care Medicine, 2021, 47 : 1258 - 1270
  • [3] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Rosas, Ivan O.
    Diaz, George
    Gottlieb, Robert L.
    Lobo, Suzana M.
    Robinson, Philip
    Hunter, Bradley D.
    Cavalcante, Adilson W.
    Overcash, J. Scott
    Hanania, Nicola A.
    Skarbnik, Alan
    Garcia-Diaz, Julia
    Gordeev, Ivan
    Carratala, Jordi
    Gordon, Oliver
    Graham, Emily
    Lewin-Koh, Nicholas
    Tsai, Larry
    Tuckwell, Katie
    Cao, Huyen
    Brainard, Diana
    Olsson, Julie K.
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1258 - 1270
  • [4] Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial
    Amra, Babak
    Ashrafi, Farzaneh
    Torki, Mehdi
    Hashemi, Marzieh
    Shirzadi, Mohamad
    Soltaninejad, Forogh
    Sadeghi, Somayeh
    Salmasi, Mehrzad
    Sami, Ramin
    Darakhshandeh, Ali
    Nasirian, Maryam
    Pourajam, Samaneh
    ADVANCED BIOMEDICAL RESEARCH, 2023, 12 (01): : 14
  • [5] Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial*
    Waters, Michael
    McKinnell, James A.
    Kalil, Andre C.
    Martin, Greg S.
    Buchman, Timothy G.
    Theess, Wiebke
    Yang, Xiaoying
    Lekkerkerker, Annemarie N.
    Staton, Tracy
    Rosenberger, Carrie M.
    Pappu, Rajita
    Wang, Yehong
    Zhang, Wenhui
    Brooks, Logan
    Cheung, Dorothy
    Galanter, Joshua
    Chen, Hubert
    Mohan, Divya
    Peck, Melicent C.
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 103 - 116
  • [6] Safety and Efficacy of Incentive Spirometer in Covid-19 Pneumonia; a Randomized Clinical Trial
    Bargahi, Mohammad
    Alavi-Moghaddam, Mostafa
    Karimi, Mehdi
    Azizan, Zahra
    Jafarzadeh, Fateme
    Javaherian, Mohammad
    Soleimantabar, Hussein
    Mirbehbahani, Seyed Hamidreza
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2024, 12 (01)
  • [7] The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial
    Hakamifard, Atousa
    Soltani, Rasool
    Maghsoudi, Ahmadreza
    Rismanbaf, Ali
    Aalinezhad, Marzieh
    Tarrahi, Mohammad Javad
    Mashayekhbakhsh, Sanaz
    Dolatshahi, Kian
    IMMUNOPATHOLOGIA PERSA, 2022, 8 (01):
  • [8] Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial
    Moon, Kyunglan
    Hong, Kyung-Wook
    Bae, In-Gyu
    TRIALS, 2021, 22 (01)
  • [9] Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial
    Kyunglan Moon
    Kyung-Wook Hong
    In-Gyu Bae
    Trials, 22
  • [10] Safety and efficacy of pamrevlumab (FG-3019) in patients with COVID-19 pneumonia: an open-label, randomized, parallel-arm phase 2 study
    Sgalla, G.
    Simonetti, J.
    Gualano, G.
    Leone, P. Maria
    Comes, A.
    Verdirosi, D.
    Poole, L.
    Kouchakji, E.
    Palmieri, F.
    Richeldi, L.
    Simonetti, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345